← Back to Intel
Insider ActivityALDX
Brady Todd C, President and CEO at Aldeyra Therapeutics, Inc., bought $418K of ALDX
Updated Jun 7, 2026
Brady Todd C
President and CEO
Aldeyra Therapeutics, Inc. ·
$ALDX
Transaction Details
| Insider | Brady Todd C |
|---|---|
| Title | President and CEO |
| Company | Aldeyra Therapeutics, Inc. |
| Ticker | ALDX |
| Transaction Type | Purchase |
| Transaction Date | 2026-06-03 |
| Shares Traded | 250,000 |
| Price Per Share | $1.6738 |
| Total Value | $418K |
| Filed Date | 2026-06-05 |
| Accession Number | 0001193125-26-259637 |
Ownership Context
| Shares Owned After Transaction | 1,721,298 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-259637
Other Insider Trades — ALDX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Brady Todd C | President and CEO | traded | — | 2026-03-27 |
| Brady Todd C | President and CEO | traded | — | 2026-03-27 |
Other Trades by Brady Todd C
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | traded | — | 2026-03-27 |
| ALDX | Aldeyra Therapeutics, Inc. | traded | — | 2026-03-27 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ALDX — Aldeyra Therapeutics, Inc. →
Track ALDX insider activity in real time on The Wire →
Get alerts when Brady Todd C files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 07, 2026 at 07:00 UTC